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hospice patients were not significantly different. Finally, as 
has been noted in acute care hospitals, the rates of device-
related infections are decreasing. 
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Use of Peripherally Inserted Central 
Catheters to Prevent Catheter-Associated 
Bloodstream Infection in Children 
Bloodstream infection (BSI) is the most common healthcare-
associated infection in pediatric intensive care units (ICUs).1,2 
Risk factors for central venous catheter (CVC)-associated BSI 
are poorly understood in middle-income developing coun-
tries. We used a prospective cohort study design to evaluate 
the infection rate and risk factors for BSI associated with 
short-term use (duration, less than 30 days) of a CVC in a 
pediatric hospital in Rio de Janeiro. 
The Instituto de Puericultura e Pediatria Martagao Gesteira 
(IPPMG) is a tertiary care pediatric hospital with 60 beds in 
6 wards. This is a reference center for patients requiring spe-
cialists in multiple diseases and admits patients aged 0-18 
years. Because there is no pediatric ICU, patients with critical 
conditions are admitted to the wards. 
All patients admitted to the wards from March 2003 
through March 2006 who had a short-term CVC inserted at 
the IPPMG were monitored daily by the infection control 
team for development of CVC-associated BSI. A structured 
questionnaire based on National Nosocomial Infection Sur-
veillance System criteria was used for active surveillance.3 If 
a patient had multiple CVCs in place simultaneously, 1 cath-
eter-day was assigned for each day of multiple CVC use, and 
the first catheter placed was used for surveillance purposes. 
CVCs inserted at another hospital, CVCs in place before ad-
mission to the wards, and CVCs placed for less than 1 day 
were excluded from analysis in this study. 
Peripherally inserted central catheters (PICCs) were in-
serted by a nurse, and other CVCs for short-term use (ie, 
those placed in the subclavian, intrajugular, and femoral 
veins) were inserted by surgeons. Before catheter insertion, 
4% chlorhexidine-germicide solution and 0.5% chlorhexi-
dine-alcohol solution were used to prepare skin. After inser-
tion, 5% chlorhexidine-alcohol solution was applied, and 
dressings were monitored by nursing staff. Conventional 
gauze dressings were applied to CVCs and were replaced with 
new dressings every 48 hours. Transparent dressings were 
applied to PICCs and were changed if bleeding and soiling 
occurred or if they did not stay in place. 
CVCs (PICCs or conventional catheters) were removed 
immediately if patients showed signs of local infection or, for 
febrile patients, if their fever had no explanation other than 
local infection. The 5-cm portion of the tip of each CVC 
removed because of suspected infection was sent to the mi-
crobiology laboratory for culture; 2 samples of peripheral 
blood from the corresponding patient were also sent for cul-
ture.4 Patients were observed for up to 48 hours after CVC 
removal. 
Data analyses were performed using Stata, version 9.0 
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(Stata). Bivariate analysis was performed using a Wilcoxon 
2-sample test (also known as the Mann-Whitney [/test). The 
Fisher exact test was used for analysis of categorical variables. 
Variables with a P value of .20 or less were included in the 
multivariate analysis. A main-effects logistic regression model 
was fitted using the stepwise maximum likelihood estimation 
technique. The level of significance for removal of a variable 
in backward regression was .10. Interactions were assessed 
using the —2 log likelihood ratio test. The Pearson x2 good-
ness-of-fit test and the Hosmer-Lemeshow test were used to 
evaluate the fitness of the model. This study was reviewed 
and approved by the IPPMG ethical research committee. 
During the study, 166 patients required 313 CVCs. Eighty-
two CVCs did not satisfy inclusion criteria, and 27 CVCs 
were not evaluated because they were associated with infec-
tion at the catheter-exit site rather than with BSI. Thus, 204 
CVCs were analyzed. Among the 166 patients in the study, 
the hospitalization duration was 12,370 patient-days, and the 
duration of CVC use was 2,197 CVC-days. The patients were 
aged 24 days to 14 years (median, 31.89 months), and 106 
(64%) were male. Of the 204 CVCs studied, 38 (16%) were 
from patients with BSI, yielding an incidence of 17.30 infec-
tions per 1,000 CVC-days. Ten BSIs were classified as CVC-
related BSI, and 28 were classified as CVC-associated BSI. 
Eighteen CVC-associated BSIs were laboratory-confirmed in-
fections, and 10 were classified as clinical sepsis. Among 204 
CVCs followed up, 53% were inserted by the Seldinger tech-
nique, 28% required surgical cut down, and 19% were placed 
percutaneously. Thirty-six percent of CVCs were inserted in 
brachiocephalic veins, 30% in internal jugular veins, 17% in 
femoral veins, 15% in subclavian veins, and 2% at another 
anatomic site. Ninety percent of CVCs were inserted using 
full-barrier precautions. 
Findings of bivariate analysis are shown in the Table. Mul-
tivariate analysis revealed that total parenteral nutrition use 
(odds ratio [OR], 2.68 [95% confidence interval {CI}, 1.13-
6.37]) and the number of CVC-days (OR, 1.06 [95% CI, 1.01-
1.12]) were independently associated with CVC-associated 
BSI. PICC use was protective against CVC-associated BSI 
(OR, 0.17 [95% CI, 0.03-0.96]). 
In this study, the incidence of CVC-associated BSI was 17.3 
infections per 1,000 catheter-days, which is greater than the 
incidence observed in most pediatric ICUs in industrialized 
countries.1,2 It is important to note that this study involved 
patients admitted to hospital wards, some of whom were in 
critical condition, and that 90% of CVCs were inserted using 
full-barrier precautions. An important risk factor for CVC-
associated BSI is the duration of CVC use.1,2 By use of multi-
variate analysis, we demonstrated that the odds of CVC-as-
sociated BSI increased a mean of 6% per CVC-day, although 
this rate is not linear and probably increases with each CVC-
day. 
We compared the risk of CVC-associated BSI among pa-
tients who received PICCs with that among patients who 
received other CVCs. Of interest, PICC use was independently 
protective against CVC-associated BSI. Several advantages of 
PICC use have been described elsewhere,5"7 but the protection 
against CVC-associated BSI conferred by PICC use has not 
been well established among children.1 To our knowledge, 
our study is the first to report such protection. 
Of final note, our hospital does not have a pediatric ICU. 
Therefore, factors associated with patients in critical condi-
T A B L E . Bivariate Analysis of Risk Factors for Central Venous Catheter (CVC)-Associated Bloodstream Infection 
(BSI) among Patients at a Brazilian Pediatric Hospital, 2003-2006 
Risk factor 
Age, months, mean 
Male sex 
Immunosuppression 
Length of stay, patient-days, mean 
Length of CVC use, CVC-days, mean 
Disease at baseline 
PICC use 
Subclavian vein insertion site 
Full-barrier precautions not used 
Antibiotic use 
TPN use 
Neutropeniab 
MDRO colonization0 
Remote-site infection 
CVC-associated BSI 
54.36 
10/38 (26) 
20/38 (52) 
11.18 
12.58 
33/37 (89) 
2/38 (5) 
8/36 (22) 
2/37 (5) 
34/38 (89) 
12/38 (32) 
3/38 (8) 
15/37 (41) 
13/38 (34) 
Non-BSI 
48.63 
54/166 (33) 
87/164 (53) 
4.17 
9.03 • 
134/166 (81) 
29/163 (18) 
25/163 (15) 
20/166 (12) 
156/166 (94) 
21/166 (13) 
16/165 (10) 
51/166 (31) 
35/164 (21) 
Relative risk (95% CI) 
0.82 (0.4 -1.67) 
0.98 (0.5-1.75) 
1.46 (0.61-3.49) 
0.29 (0.07-1.22) 
1.47 (0.70-2.78) 
0.39 (0.12-1.82) 
0.95 (0.2-1.5) 
2.46 (1.34-4.24) 
0.83 (0.3-2.4) 
1.32 (0.83-2.60) 
1.62 (1.28-4.00) 
P 
.38 
.45 
.96 
<01 
<.01a 
.38 
.04' 
.36 
.23 
.30 
.004" 
.73 
.18" 
.007* 
NOTE. Data are proportion (%) of patients, unless otherwise indicated. CI, confidence interval; MDRO, multidrug-resistant 
organism; PICC, peripherally inserted central catheter; TPN, total parenteral nutrition. 
* Included in the multivariate analysis. 
b
 Denned as a granulocyte count of ^500 cells/mm3. 
c
 Methicillin-resistant Staphylococcus aureus and gram-negative extended-spectrum ^-lactamase producers. 
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tion, such as mechanical ventilation, arterial catheter use, and 
urinary catheter use, were not studied because of sample size 
limitations. 
ACKNOWLEDGMENTS 
Potential conflicts of interest. All authors report no conflicts of interest rel-
evant to this article. 
E. Goes-Silva, RN, MSc; T. F. Abreu, MD, PhD; 
A. C. C. Frota, MD, MSc; C. L. Pessoa-Silva, MD, PhD; 
A. J. L. A. Cunha, MD, PhD; C. B. Hofer, MD, PhD 
From the Instituto de Puericultura e Pediatria Martagao Gesteira, 
Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil (E.G.-S., T.F.A., 
A.C.C.F., A.J.L.A., C.B.H.); and the World Health Organization, Geneva, 
Switzerland (C.L.P.-S.). 
Address reprint requests to Cristina Barroso Hofer, MD, PhD, Rua Lopes 
Quintas, 340/106-Jardim Botanico, Rio de Janeiro, Brazil 22460-010 
(cbhofer@hucff.ufrj.br). 
Received January 14, 2009; accepted May 4, 2009; electronically published 
August 31, 2009. 
© 2009 by The Society for Healthcare Epidemiology of America. All rights 
reserved. 0899-823X/2009/3010-0017$15.00. DOI: 10.1086/606040 
R E F E R E N C E S 
1. Newman CD. Catheter related bloodstream infection in the pediatric in-
tensive care unit. Semin Pediatr Infect Dis 2006; 17:20-22. 
2. Garcia-Teresa MA, Casado-Flores J, Delgado Dominguez MA, et al. In-
fectious complications or percutaneous central venous catheterization in 
pediatric patients: a Spanish multicenter study. Spanish Central venous 
Catheter Pediatric Study Group. Intensive Care Med 2007; 33:466-476. 
3. Centers for Disease Control and Prevention (CDC). NNIS Manual. At-
lanta, GA: Centers for Disease Control and Prevention; 1994. 
4. Maki DG, Weise CE, Sarafin HW. A semiquantitative culture method for 
identifying intravenous catheter related infection. N Engl J Med 1977; 296: 
1305-1309. 
5. Gamulka B, Mendoza C, Connolly B. Evaluation of a unique nurse-in-
serted peripherally inserted central catheter program. Pediatrics 2005; 115: 
1602-1606. 
6. Matsuzaki A, Suminoe A, Koga Y, Hatano M, Hattori S, Hara T. A long 
term use of PICC for cancer chemotherapy in children. Support Care 
Cancer 2006; 14:153-160. 
7. Newman CD, Jeanine MG. Peripherally inserted central catheter in pe-
diatric critical care: one center's experience [abstract 174-T]. Crit Care 
Med 2005; 33:A154. 
Nosocomial Transmission of Undetected, 
Imported Measles in Taiwan, 2008 
Measles remains a leading cause of death among young chil-
dren.1 Measles is highly contagious, and nosocomial trans-
mission that has generated clusters of secondary cases has 
been described.2 Healthcare workers (HCWs) have a nearly 
19-fold higher risk of infection with measles compared with 
the general population.3 This report describes nosocomial 
measles in 7 children and 1 HCW in Taiwan. The isolation 
of measles virus genotype HI and the recent arrival from 
China of the source patient who sparked the epidemic in-
dicate that the disease was imported from China. 
In Taiwan, the transmission of indigenous measles has been 
successfully interrupted by massive measles vaccination pro-
grams, which were introduced in 1978. High vaccination cov-
erage (90% at first dose and 95% at second dose) has been 
achieved since 1996.4"11 Fewer than 10 confirmed cases of 
measles have occurred annually since 2003.4"12 
This investigation was begun when a 39-year-old pediatric 
HCW and a 9-month-old pediatric patient (index patient) 
developed measles. The index patient was admitted to Kao-
hsiung Veterans General Hospital on December 8, 2008, with 
acute bronchitis and was discharged on December 17 but was 
readmitted on December 25 because of 2 days' fever and rash. 
The measles virus HI genotype was isolated from throat swab 
samples obtained from the index patient (patient 1) and the 
infected HCW (patient 2). The source patient (patient 3) who 
transmitted the virus to index patient 1 was a 29-month-old 
child with fever and rash attributed to Kawasaki disease who 
stayed in the same hospital room as index patient 1 from 
December 13 through 17, 2008. Investigation revealed that 
source patient 3 had had contact with a cousin aged 28 
months (patient 4) who had measles after being hospitalized 
in another hospital (hospital B) in early December 2008. The 
source patient who sparked the epidemic (patient 5) turned 
out to be a 20-month-old child who had recently arrived 
from China. On November 1, 2008, source patient 5 had 
received the mumps, measles, and rubella (MMR) vaccine. 
On November 5, 2008, he was admitted to hospital B with 
a fever and rash that had lasted 2 days. Subsequently, 4 pe-
diatric inpatients in hospital B (patients 4, 6, 7, and 8) de-
veloped measles, including the cousin (patient 4) of source 
patient 5 (Table). The HI genotype of the measles virus iso-
lated from a throat swab sample obtained from source patient 
5 had 100% homology in the 456 nucleotides that encode 
the COOH terminus of the nucleoprotein (N) with the viral 
genotype found in the 2 patients in our hospital and 1 patient 
in hospital B. All patients recovered uneventfully. None of 
the other children had received measles vaccination prior to 
becoming ill. Given the possibility that the outbreak in the 
pediatric ward of Kaohsiung Veterans General Hospital might 
spread within the hospital and the community, we initiated 
active contact tracing, investigating exposed HCWs and chil-
dren hospitalized in the pediatric department. 
All pediatric patients admitted during the contagious pe-
riod were traced by telephone to ascertain their history of 
vaccination, measles infection, and symptoms of fever and 
rash after discharge. Serological tests for measles were per-
formed on children who had fever and rash when they were 
admitted, on pediatric nurses, and on symptomatic HCWs. 
HCWs who were exposed to the virus in the emergency and 
outpatient departments were observed for fever and rash. 
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